Conformational perturbation of SARS-CoV-2 spike protein using N-acetyl cysteine: an exploration of probable mechanism of action to combat COVID-19

被引:1
|
作者
Debnath, Utsab [1 ]
Mitra, Amrita [2 ]
Dewaker, Varun [3 ]
Prabhakar, Yenamandra S. [3 ]
Tadala, Raghu [4 ]
Krishnan, Kiran [4 ]
Wagh, Padmakar [4 ]
Velusamy, Umashankar [4 ]
Baliyan, Aastha [5 ]
Kurpad, Anura V. [6 ]
Bhattacharyya, Parthasarathi [7 ]
Mandal, Amit Kumar [5 ]
机构
[1] Univ Petr & Energy Studies, Sch Hlth Sci & Technol, Dehra Dun, India
[2] St Johns Res Inst, Div Mol Med, Clin Prote Unit, Bangalore, India
[3] CSIR, Cent Drug Res Inst, Med & Proc Chem Div, Lucknow, India
[4] Waters India Pvt Ltd 36A, Bengaluru, India
[5] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Nadia 741246, W Bengal, India
[6] St Johns Med Coll, Dept Physiol, Bangalore, India
[7] Inst Pulmocare & Res, Clin Div, Kolkata, India
关键词
SARS-CoV-2; spike protein; disulfide bonds; N-acetyl cysteine (NAC); angiotensin-converting enzyme 2 (ACE2); mass spectrometry; proteomics; molecular docking; MD simulation; MOLECULAR-DYNAMICS; WEB SERVER; ANALOGS;
D O I
10.1080/07391102.2023.2234031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Spike protein is used to target human ACE2 receptor for viral fusion into the human cell. N-acetyl cysteine can interestingly inhibit this viral fusion process by increasing the probability of structural deformation of this viral spike protein. This process may indirectly reduce the intermolecular binding affinity between two enzymes
引用
收藏
页码:5042 / 5052
页数:11
相关论文
共 50 条
  • [31] Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19
    Toor, Himanshu G.
    Banerjee, Devjani I.
    Rath, Soumya Lipsa
    Darji, Siddhi A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 890
  • [32] Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4-13 Months after COVID-19
    Kolosova, Evgeniia A.
    Shaprova, Olga N.
    Shanshin, Daniil, V
    Nesmeyanova, Valentina S.
    Merkuleva, Iuliia A.
    Belenkaya, Svetlana, V
    Isaeva, Anastasiya A.
    Nikitin, Artem O.
    Volosnikova, Ekaterina A.
    Nikulina, Yuliya A.
    Nikonorova, Marina A.
    Shcherbakov, Dmitry N.
    Elchaninova, Svetlana A.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [33] Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection
    Andrey V. Letarov
    Vladislav V. Babenko
    Eugene E. Kulikov
    Biochemistry (Moscow), 2021, 86 : 257 - 261
  • [34] Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection
    Letarov, Andrey, V
    Babenko, Vladislav V.
    Kulikov, Eugene E.
    BIOCHEMISTRY-MOSCOW, 2021, 86 (03) : 257 - 261
  • [35] SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines
    Suzuki, Yuichiro J.
    Gychka, Sergiy G.
    VACCINES, 2021, 9 (01) : 1 - 8
  • [36] Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19
    Scheim, David E.
    Vottero, Paola
    Santin, Alessandro D.
    Hirsh, Allen G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
  • [37] COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications
    Kalra, Rajkumar Singh
    Dhanjal, Jaspreet Kaur
    Meena, Avtar Singh
    Kalel, Vishal C.
    Dahiya, Surya
    Singh, Birbal
    Dewanjee, Saikat
    Kandimalla, Ramesh
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [38] Proposal of De Novo Antigen Test for COVID-19: Ultrasensitive Detection of Spike Proteins of SARS-CoV-2
    Kyosei, Yuta
    Namba, Mayuri
    Yamura, Sou
    Takeuchi, Rikiya
    Aoki, Noriko
    Nakaishi, Kazunari
    Watabe, Satoshi
    Ito, Etsuro
    DIAGNOSTICS, 2020, 10 (08)
  • [39] Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
    Bojadzic, Damir
    Alcazar, Oscar
    Buchwald, Peter
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [40] COVID-19 Salivary Protein Profile: Unravelling Molecular Aspects of SARS-CoV-2 Infection
    Esteves, Eduardo
    Mendes, Vera M.
    Manadas, Bruno
    Lopes, Rafaela
    Bernardino, Liliana
    Correia, Maria Jose
    Barros, Marlene
    Esteves, Ana Cristina
    Rosa, Nuno
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)